We're headed to AMP 2019!
Baltimore, MD | November 7-9, 2019
We hope you will stop by our booth #2856 for a demo or one of our Innovation Spotlight Talks at Stage 1:
Thursday, Nov 7th – 2:15pm – 2:45pm
State of the Art Clinical Copy Number Variant Analysis in Next-Gen Sequencing Data: Gene Panels, Whole Exome, Whole Genome
Saturday, Nov 9th – 10:00am – 10:30am
Clinical Variant Analysis: Applying the AMP & ACMG Guidelines in the Clinical Practice
See our full demo schedule, or request a one-on-one meeting with our team here.
Reflecting on ASHG 2019
By Andreas Scherer, Ph.D.
President & CEO
As our team returns from another successful ASHG conference, I would like to reflect on the great memories, connections, and future plans that were made at this meeting. First, I will start by thanking everyone involved with the superb planning and execution of the conference. We are thankful to have this opportunity to connect with our customers, partners, and friends... Read More
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
By Darby Kammeraad
Field Application Scientist Manager
Join us for our upcoming webcast, Nov. 6 at 12pm EST, as we delve into VSWarehouse with a focus on our new capability of storing somatic variant projects and catalogs built for the AMP Guidelines within VSClinical. Previous webcasts have gone into great detail on the features and processing of somatic variants following the automated AMP Guidelines in VSClinical... Read More
Oncogenicity Scoring in VSClinical
By Nathan Fortier, Ph.D.
Director of Research
Before examining the clinical evidence associated with a specific mutation, a clinician must establish that the variant is likely to be a driver mutation which generates functional changes that enhance tumor cell proliferation. Our recent blog series “Following the AMP Guidelines with VSClinical” briefly mentioned how the oncogenicity scoring system in VSClinical could be used to automate and assist the... Read More